Cargando…
Clinical Prescription-Protein-Small Molecule-Disease Strategy (CPSD), A New Strategy for Chinese Medicine Development: A Case Study in Cardiovascular Diseases
Chinese medicine is a national treasure that has been passed down for thousands of years in China. According to the statistics of the World Health Organization, there are currently four billion people in the world who use Chinese medicine to treat diseases, accounting for 80% of the world’s total po...
Autores principales: | Guo, Yong-Zhi, Jiang, Ying-Nan, Li, Yi-Fang, Kurihara, Hiroshi, Dai, Yi, He, Rong-Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987446/ https://www.ncbi.nlm.nih.gov/pubmed/32038243 http://dx.doi.org/10.3389/fphar.2019.01564 |
Ejemplares similares
-
Effect of Traditional Chinese Medicine on the Cardiovascular Diseases
por: Jiang, Yang, et al.
Publicado: (2022) -
Chinese Herbal Medicine in the Treatment of Depression in Parkinson’s Disease: From Molecules to Systems
por: Zhang, Yi, et al.
Publicado: (2022) -
Traditional Chinese Medicine as a Promising Strategy for the Treatment of Alzheimer’s Disease Complicated With Osteoporosis
por: Xu, Weifan, et al.
Publicado: (2022) -
Utilization patterns and prescription characteristics of traditional Chinese medicine among patients with irritable bowel syndrome in Taiwan
por: Gu, Ye, et al.
Publicado: (2023) -
Chinese Herbal Medicine on Cardiovascular Diseases and the Mechanisms of Action
por: Liu, Cuiqing, et al.
Publicado: (2016)